Merck's HIV vaccine flop brings vectors under closer scrutiny

Nat Biotechnol. 2008 Jan;26(1):3-4. doi: 10.1038/nbt0108-3.
No abstract available

Publication types

  • News

MeSH terms

  • AIDS Vaccines / adverse effects*
  • AIDS Vaccines / immunology*
  • AIDS Vaccines / therapeutic use
  • Acquired Immunodeficiency Syndrome / etiology*
  • Acquired Immunodeficiency Syndrome / prevention & control
  • Clinical Trials, Phase II as Topic*
  • Drug Approval*
  • Genetic Vectors / adverse effects
  • Humans
  • United States
  • Viral Vaccines / adverse effects*
  • Viral Vaccines / genetics
  • Viral Vaccines / immunology*
  • Viral Vaccines / therapeutic use

Substances

  • AIDS Vaccines
  • Viral Vaccines